Human achaete-scute homologue (hASH1) mRNA level as a diagnostic marker to distinguish esthesioneuroblastoma from poorly differentiated tumors arising in the sinonasal tract

American Journal of Clinical Pathology

Volumn 122, Issue 1, 2004, Pages 100-105

  Mhawech, Paulette ^a,c   Berczy, Margaret ^a   Assaly, Mounia ^a   Herrmann, Francois ^a   Bouzourene, Hanifa ^b   Allal, Abdelkarim S ^a   Dulguerov, Pavel ^a   Schwaller, Jürg ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c c/o Johnny Depaolo ^*  (United States)

Author keywords

Esthesioneuroblastoma; Human achaete scute homologue (hASH1) expression; Olfactory neuroblastoma; Poorly differentiated tumors

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; ESTHESIONEUROBLASTOMA; GENE; HASH1 GENE; HEAD AND NECK TUMOR; HUMAN; HUMAN ACHAETE SCUTE HOMOLOGUE GENE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; NEUROBLASTOMA; NOSE CAVITY TUMOR; NUCLEOTIDE SEQUENCE; OLFACTORY NERVE; OLFACTORY NERVE DISEASE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

EID: 3042849071     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/QD0K9Q1JBH6B5GQQ     Document Type: Article

References (25)

1. Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumor in 1924. Anticancer Res. 1997;17:2383-2406.
2. Argiris A, Dutra J, Tseke P, et al. Esthesioneuroblastoma: the Northwestern University experience. Laryngoscope. 2003;113:155-160.
3. Camey ME, O'Reilly RC, Sholevar B, et al. Expression of the human achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma). J Neurooncol. 1995;26:35-43.
4. Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope. 1992;102:843-849.
5. Dulguerov P, Allal AS, Calacaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001;2:683-690.
6. Hyams VJ. Olfactory neuroblastoma. In: Hyams VJ, Batsakis JG, Michaels L, eds. Tumors of the Upper Respiratory Tract and Ear. Washington, DC: Armed Forces Institute of Pathology; 1988:240-248. Atlas of Tumor Pathology; Second series, Fascicle 25.
7. Hyams VJ. Olfactory neuroblastoma. In: Hyams VJ, Batsakis JG, Michaels L, eds. Tumors of the Upper Respiratory Tract and Ear. Washington, DC: Armed Forces Institute of Pathology; 1988:240-248. Atlas of Tumor Pathology; Second series, Fascicle 25.
8. Chan JKC. Advances in immunohistochemistry: impact on surgical practice. Semin Diagn Pathol. 2000;17:170-177.
9. Devoe K, Weidner N. Immunohistochemistry of small round-cell tumors. Semin Diagn Pathol. 2000;17:216-224.
10. Sommer L, Shah N, Rao M, et al. The cellular function of MASH1 in autonomic neurogenesis. Neuron. 1995;15:1245-1258.
11. Johnson JE, Birren SJ, Anderson DJ. Two rat homologues of Drosophila achaete-scute specifically expressed in neuronal precursors. Nature. 1990;346:858-861.
12. Guillemot F, Lo LC, Johnson JE, et al. Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell. 1993;75:463-476.
13. Ball DW, Azzoli CG, Bylin SB, et al. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci U S A. 1993;90:5648-5652.
14. Carney DN, Gazdar AF, Bepler G, et al. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 1985;45:2913-2923.
15. Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol. 2002;15:264-278.
16. Oskoulan RJ, Jane JA, Dumont AS, et al. Esthesioneuroblastoma: clinical presentation, radiological, and pathological features, treatment, review of the literature, and the University of Virginia experience. Neurosurg Focus. 2002;12:1-9.
17. Thompson LDR, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas. Am J Surg Pathol. 2003;27:594-611.
18. Lund VJ, Howard D, Wei W, et al. Olfactory neuroblastoma: past, present, and future? Laryngoscope. 2003;113:502-507.
19. Cau E, Casarosa S, Guillemot F. Mash1 and Ngn1 control distinct steps of determination and differentiation in the olfactory sensory neuron lineage. Development. 2002;129:1871-1880.
20. Sriuranpong V, Borges MW, Strock CL, et al. Notch signaling induces rapid degradation of achaete-scute homolog 1. Mol Cell Biol. 2002;22:3129-3139.
21. Clegg N, Ferguson C, True LD, et al. Molecular characterization of prostatic small-cell neuroendocrine carcinoma. Prostate. 2003;55:55-64.
22. Westerman BA, Neijenhuis S, Poutsma A, et al. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features. Clin Cancer Res. 2002;8:1082-1086.
23. Soderholm H, Ortoft E, Johansson I, et al. Human achaete-scute homologue 1 (HASH-1) is downregulated in differentiating neuroblastoma cells. Biochem Biophys Res Commun. 1999;256:557-563.
24. Levine PA, Frierson HF, Stewart FM, et al. Sinonasal undifferentiated carcinoma: a distinctive and highly aggressive neoplasm. Laryngoscope. 1987;97:905-908.
25. Miyamoto RC, Gleich LL, Biddinger PW, et al. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis. Laryngoscope. 2000;110:1262-1265.